Invention Grant
- Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers
-
Application No.: US16017303Application Date: 2018-06-25
-
Publication No.: US10675255B2Publication Date: 2020-06-09
- Inventor: Elazar Rabbani , James J. Donegan
- Applicant: Enzo Biochem, Inc.
- Applicant Address: US NY New York
- Assignee: Enzo Bochem, Inc.
- Current Assignee: Enzo Bochem, Inc.
- Current Assignee Address: US NY New York
- Agent Paul Diamond, Esq.
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K31/4245 ; A61K45/06 ; A61K31/135 ; A61P35/00 ; A61P35/02
Abstract:
The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.
Public/Granted literature
- US20180369169A1 SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS Public/Granted day:2018-12-27
Information query
